Top Markets
Coin of the day
Adynxx, Inc. Adynxx, Inc.

Adynxx, Inc.

ADYX
Rangering i aksjer #42632
Adynxx, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating... Adynxx, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating and commercializing novel transcription factor decoy technologies to combat pain and inflammatory conditions. Central to its efforts is the AYX platform of transcription factor decoys, which includes brivoligide, currently progressing through Phase II clinical development for reducing post-surgical discomfort. Additionally, AYX2 is a pre-clinical candidate being explored for its potential in treating localized chronic pain. Established in 2007, the company's corporate headquarters are situated in San Francisco, California.
Aksjekurs
$0.0001
Sist synkronisert: 2026-08-11
Markedsverdi
$581.00
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Adynxx, Inc. (ADYX)

Kategori

EPS for Adynxx, Inc. (ADYX)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Adynxx, Inc. er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Adynxx, Inc. fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter